Lutris Pharma Shares Promising Phase 2 Results for LUT014 Gel at EADV Congress #Israel #Tel_Aviv #LUT014 #Gefitinib #Anti-Cancer
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialLutris Pharma to Share Latest Findings on LUT014 Gel at EADV Congress #Vienna #Austria #Lutris_Pharma #LUT014 #EADV_Congress